Trial Profile
Compromised Microcirculation in Women With Polycystic Ovary Syndrome.
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ganirelix (Primary) ; Methyltestosterone (Primary)
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 07 Jul 2010 New trial record